News in Brief

Abzena remodels ADC facility in Pennsylvania

By Staff Reporter

- Last updated on GMT

Abzena has equipped its $5m Pennsylvania bioconjugation suite with Sartoius and GE Healthcare single-use equipment.

The $5m (€4m) investment at the firm’s site in Bristol, Pennsylvania – added when Abzena acquired The Chemistry Research Solution in 2015​​ – was announced last year​, and this week the firm said facility remodelling for the GMP manufacturing suite has been completed.

Empty space in the building is set to provide capacity for antibody-drug conjugation (ADC) services, and will allow Abzena to expand its process chemistry capabilities, including HPAPI process chemistry.

The remodelling was carried out by local contractors in Bristol, an Abzena spokesperson told Biopharma-Reporter, and the suite is scheduled for completion around the end of the second quarter of 2018.

We were told: The facility is equipped with Sartorius Levmixer, FlexAct & AlphaPlus and GE Akta single-use process equipment.”

Related news

Show more

Related products

show more

Difco TC Yeastolate UF in scale-up optimization

Difco TC Yeastolate UF in scale-up optimization

Content provided by Thermo Fisher Scientific Gibco Culture for Bioprocessing | 16-Oct-2023 | White Paper

Review the impact of—not only adding peptones as a supplement to your cell culture—but also the importance of concentration and timing as a feed strategy...

Related suppliers